HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient.
HIV is an increasingly common cause of thrombotic thrombocytopaenic purpura in the United Kingdom. We report a patient with both conditions who presented major therapeutic and ethical challenges. Furthermore, he was recalcitrant to all established therapies, and was, therefore, the first reported HIV patient with thrombotic thrombocytopaenic purpura to receive rituximab.
Ross
Clare L
CL
Department of Intensive Care, Guy's and St Thomas' NHS Trust, St Thomas' Hospital, London, UK.
Hunt
Beverley J
BJ
Wyncoll
Duncan
D
Hodgkiss
Andrew
A
Peters
Barry
B